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Structural imaging biomarkers of sudden
unexpected death in epilepsy
Britta Wandschneider,1,2 Matthias Koepp,1,2 Catherine Scott,1,2 Caroline Micallef,1,2
Simona Balestrini,1,2,3 Sanjay M. Sisodiya,1,2,4 Maria Thom,1,2,4 Ronald M. Harper,4,5
Josemir W. Sander,1,2,4,6 Sjoerd B. Vos,1,2,7 John S. Duncan,1,2 Samden Lhatoo4,8 and
Beate Diehl1,2,4
Sudden unexpected death in epilepsy is a major cause of premature death in people with epilepsy. We aimed to assess whether
structural changes potentially attributable to sudden death pathogenesis were present on magnetic resonance imaging in people
who subsequently died of sudden unexpected death in epilepsy. In a retrospective, voxel-based analysis of T1 volume scans, we
compared grey matter volumes in 12 cases of sudden unexpected death in epilepsy (two definite, 10 probable; eight males),
acquired 2 years [median, interquartile range (IQR) 2.8] before death [median (IQR) age at scanning 33.5 (22) years], with 34
people at high risk [age 30.5 (12); 19 males], 19 at low risk [age 30 (7.5); 12 males] of sudden death, and 15 healthy controls [age
37 (16); seven males]. At-risk subjects were defined based on risk factors of sudden unexpected death in epilepsy identified in a
recent combined risk factor analysis. We identified increased grey matter volume in the right anterior hippocampus/amygdala and
parahippocampus in sudden death cases and people at high risk, when compared to those at low risk and controls. Compared to
controls, posterior thalamic grey matter volume, an area mediating oxygen regulation, was reduced in cases of sudden unexpected
death in epilepsy and subjects at high risk. The extent of reduction correlated with disease duration in all subjects with epilepsy.
Increased amygdalo-hippocampal grey matter volume with right-sided changes is consistent with histo-pathological findings re-
ported in sudden infant death syndrome. We speculate that the right-sided predominance reflects asymmetric central influences on
autonomic outflow, contributing to cardiac arrhythmia. Pulvinar damage may impair hypoxia regulation. The imaging findings in
sudden unexpected death in epilepsy and people at high risk may be useful as a biomarker for risk-stratification in future studies.
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Introduction
The incidence of sudden death is 20-fold higher in people
with epilepsy than in the general population; sudden unex-
pected death in epilepsy (SUDEP) is the most common
cause of premature death in people with chronic epilepsy.
There is currently little understanding of the underlying
mechanisms of SUDEP, and post-mortem histopathology
has shown no pathognomonic characteristics (Surges
et al., 2009; Shorvon and Tomson, 2011; Surges and
Sander, 2012). Meta-analyses of SUDEP risk factors
(Hesdorffer et al., 2011; Ryvlin et al., 2013a) have identi-
fied frequent convulsive seizures (53/year) as a major risk
factor and several studies indicate that unsupervised noc-
turnal seizures significantly contribute to SUDEP risk
(Lamberts et al., 2012). The Mortality in Epilepsy
Monitoring Unit Study (MORTEMUS) reported a consist-
ent pattern in video-EEG monitored SUDEP cases, of a
convulsive seizure, followed by early and fatal cardio-
respiratory dysfunction (Ryvlin et al., 2013b). Some studies
support a primary respiratory cause with central apnoea,
which has been related to postictal generalized EEG sup-
pression, indicating profound depression of CNS functions
(Lhatoo et al., 2010). Other studies report primary peri-
ictal cardiac arrhythmias and impaired heart rate variability
accompanying SUDEP (Surges et al., 2010).
One recent imaging investigation (Mueller et al., 2014)
reported severe volume loss in the dorsal mesencephalon in
two SUDEP cases. A resting-state functional connectivity
study identified reduced functional connectivity between
the pons and right thalamus, the midbrain and right thal-
amus, the anterior cingulate cortex bilaterally and the thal-
amus, and the right and left thalamus in subjects at high
risk compared to those at low risk of SUDEP (Tang et al.,
2014). Imaging studies in other conditions with high risk of
sudden death have also shown structural changes in brain
regions bearing autonomic regulatory or respiratory func-
tions, i.e. the dorsal and ventral medulla, putamen, and
bilateral insular cortices in recent-onset obstructive sleep
apnoea (Kumar et al., 2014), and the hypothalamus, pos-
terior thalamus, caudal raphe, locus coeruleus, insular
cortex and lateral medulla in congenital central hypoventi-
lation syndrome. People suffering from the latter condition
are especially at risk for sudden death (Patwari et al.,
2010). Neuropathological studies in sudden infant death
syndrome (SIDS) report brainstem abnormalities, i.e. brain-
stem gliosis and defects of neurotransmission in the me-
dulla (Paine et al., 2014). Dentate gyrus abnormalities in
the hippocampus were reported in a large subset of 153
sudden infant death syndrome cases, and may reflect de-
fective neuronal migration and proliferation (Kinney et al.,
2009, 2015).
Mice carrying mutations in the Kv1.1 potassium and
SCN1A sodium channels have many phenotypes of
human SUDEP, e.g. frequent convulsive seizures and pre-
mature death. A recent study in these mutant mice demon-
strated that cortical EEG suppression coincided with
spreading depolarization in the dorsal medulla, a region
controlling cardiorespiratory pace making. Depolarizing
blockade of these cells prevents normal autoresuscitation
and produces cardiorespiratory arrest (Aiba and Noebels,
2015). To elucidate which brain regions may be implicated
in SUDEP, we investigated whether regional abnormalities
in grey matter volume appear in those who had SUDEP,
compared to healthy controls. Due to the low incidence of
SUDEP, exploring enriched risk groups has been suggested
as a means to increase the yield of future studies (Ryvlin
et al., 2013a). We explored whether regional imaging find-
ings in people who died of SUDEP can be reproduced in a
larger cohort of subjects at high risk for SUDEP. To assess
whether imaging findings are common to SUDEP and those
at high risk, independent from other epilepsy-related fac-
tors, we compared SUDEP cases and those at high risk to a
population presumed to be at low risk of SUDEP. We also
compared subjects at high risk and low risk of SUDEP to
healthy controls.
Materials and methods
This retrospective study was conducted at a UK tertiary refer-
ral centre for epilepsy as part of database research on the
‘Prevention and Risk Identification of SUDEP’, approved by
the National Research Ethics Committee (14/SW/0021).
The scans for SUDEP cases, those at low and high risk of
SUDEP, and healthy controls were obtained from an overlap-
ping period of case ascertainment, ensuring same imaging
protocols were used for acquisition.
Subjects with epilepsy were identified from a general clinical
database at the tertiary referral centre. We identified 12 people
who died with definite or probable SUDEP, and matched those
with 53 living subjects with epilepsy identified from the same
database according to the criteria below. All subjects had to
have undergone a high-resolution T1 volume scan using the
identical 3 T MRI scanner as part of their clinical care.
Individuals with major brain lesions, such as those after partial
temporal lobe resection, were not included to avoid problems
with imaging normalization. Sufficient clinical data had to be
available to subsequently identify subjects at low or high risk
of SUDEP, as described below. All three groups were matched
for gender, age, epilepsy syndrome, and epilepsy duration to
control for duration-related structural changes. Groups were
also matched for lesion pathology where possible.
Healthy controls were comparable to the epilepsy popula-
tions for gender and age.
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Characteristics of subjects who
died suddenly
Those deceased were classified as probable (n = 10) or def-
inite (n = 2) SUDEP, according to a recent classification
(Nashef et al., 2012). The median age at death was 35.5
[interquartile range (IQR) 2.8] years. Scans were acquired
at a median of 2 (IQR 2.8) years antemortem.
Videotelemetry data of seizures were available in five
SUDEP cases. Further clinical information on the SUDEP
cases are shown in Table 1. SUDEP, subjects at high or
low risk, as well as control subjects, were comparable for
gender and age at scan (Table 2).
Characteristics of people at high or
low risk for SUDEP
A risk score was created for each subject according to the most
robust epilepsy-specific risk factors for SUDEP identified in
recent combined-risk factor analyses (Hesdorffer et al., 2011)
that were also implemented in a recent SUDEP imaging study
(Tang et al., 2014). Odds ratios for individual SUDEP risk
factors were therefore adjusted for different study groups.
Those with either nocturnal seizures [odds ratio (OR) = 3.9],
or frequent (53/year) convulsive seizures (OR = 15.46), were
considered ‘high risk.’ Increased SUDEP risk is also associated
with young age at disease onset (onset age5 16 years:
OR = 1.72), and long disease duration (duration415 years:
OR = 1.95) (Hesdorffer et al., 2011; Lamberts et al., 2012).
For each subject, odds ratios for risk factors were added to
define an individual overall risk score. In the SUDEP cohort,
11 of 12 SUDEP cases (91.7%) were correctly identified as
high risk subjects if the summed risk score was at least 3.9
(median risk score 19.1, IQR 16.7). One subject with juvenile
myoclonic epilepsy had died, probably from SUDEP, but was
not known to have suffered from nocturnal seizures or fre-
quent convulsive seizures. A cut-off of 3.9 was therefore
used to stratify others into those with high (53.9) and low
risk (53.9) of SUDEP.
Individual risk scores and pathology identified on MRI of
people at low and high risk for SUDEP are listed in
Supplementary Table 1.
SUDEP cases, and those at low and high risk, were
matched for epilepsy syndrome (SUDEP: 1/12 generalized
genetic epilepsy; high risk: 0/34; low risk: 3/19), and as
far as possible for type of pathology (Supplementary Table
2). We were primarily interested in identifying common
structures and pathophysiological mechanisms underlying
SUDEP and high risk for SUDEP, and the majority of
those at low risk (10/19), and high risk (22/34), had no
identifiable lesions on a high-resolution 3 T epilepsy proto-
col clinical MRI brain scan. Videotelemetry data of seizures
were available in 30/34 of those at high risk, and 7/19 at
low risk. Further information regarding epilepsy classifica-
tion (as per videotelemetry and/or history) is shown in
Supplementary Table 3.
Controls
Scans of 15 age- and gender-matched healthy control subjects
were included from a previous study (Stretton et al., 2013). All
controls had normal MRI scans.
Table 1 Additional clinical characteristics of the SUDEP cohort
Case Epilepsy syndrome SUDEP
Category
Lesion on visual in-
spection of MRI by
neuroradiologist
Duration tonic
phase (s)
PGES Duration
PGES (s)
1 Juvenile myoclonic
epilepsy
Probable No N/A N/A N/A
2 Focal, left temporal
Primary generalized
Probable Bulky left amygdala with
mild FLAIR signal
increase
N/A no N/A
3 Focal, bitemporal Probable no 11 yes 30–43
4 Focal, probably
bitemporal
Probable no N/A N/A N/A
5 Multifocal, left mesial
temporal and
frontal
Probable Left hippocampal
sclerosis
10 yes 33
6 Focal, frontal Probable no N/A N/A N/A
7 Focal, unclassified Definite Bilateral periventricular
leucomalacia
N/A N/A N/A
8 Focal, frontal Probable Left hippocampal
sclerosis
N/A yes 5
9 Focal, left hemisphere
neocortical
definite Cavernoma left superior
frontal gyrus
6 - 23 no N/A
10 Unclassified Probable Cavernoma right inferior
frontal, in white matter
N/A N/A N/A
11 Focal, probably
bitemporal
Probable Enlarged left amygdala4
hippocampus
N/A N/A N/A
12 Focal, left hemisphere Probable Right superior temporal
DNET
N/A N/A N/A
DNET = dysembryoplastic neuroepithelial tumour; FLAIR = fluid-attenuated inversion recovery; N/A =not applicable; PGES = postictal generalized EEG suppression.
Imaging biomarkers in SUDEP BRAIN 2015: 138; 2907–2919 | 2909
MRI data acquisition
All participants had been previously scanned on the same 3 T
GE Signa HDx scanner (General Electric), and were scanned
with identical acquisition parameters. We used standard ima-
ging gradients, with a maximum strength of 40mT/m and slew
rate of 150T/m/s. As part of the clinical sequences, a coronal
T1-weighted volumetric (3D) scan was acquired with 170 con-
tiguous 1.1-mm thick slices (matrix 256  256, in-plane reso-
lution 0.9375  0.9375mm).
MRI data analysis
We used the Voxel Based Morphometry 8 toolbox (http://dbm.
neuro.uni-jena.de/vbm), implemented in Statistical Parametric
Mapping (SPM) 8 software (http://www.fil.ion.ucl.ac.uk/spm)
for data analysis. Preprocessing included spatial normalization
to the Montreal Neurological Institute (MNI) template, seg-
mentation into the different tissue classes (grey matter, white
matter, CSF), and modulation to correct for volume changes
due to normalization. Intersubject registration was optimized
by using the DARTEL (Diffeomorphic Anatomical
Registration Through Exponentiated Lie Algebra) algorithm.
A quality check implemented in the VBM8 Toolbox did not
identify any outliers, and grey matter images were then
smoothed with a 10-mm full-width at half-maximum
Gaussian kernel (Yasuda et al., 2010).
The smoothed grey matter images were entered into a full-
factorial design with group as factor to test for local differ-
ences in grey matter volume between groups. Voxels with grey
matter values 50.2 (absolute threshold masking) were
excluded to avoid edge effects between different tissue types.
Age at scan was entered as a nuisance variable into the model.
The statistical threshold was set at P5 0.001, with a min-
imum cluster size of 30 contiguous voxels.
Statistical analysis of demographical
and clinical data
Statistical analysis of demographical and clinical data was per-
formed with SPSS Version 20.0 (SPSS Inc.). Pearson’s chi-
square test with an exact significance test for cells with a
count of less than five was used for dichotomous data.
Kruskal-Wallis test was used for all other data (Table 2).
Results
Demographic and clinical data
All groups were comparable for gender and age at scan.
Epilepsy groups were generally comparable for clinical par-
ameters, except for factors included in the risk scoring, i.e.
frequent convulsive seizures, nocturnal seizures, and onset
of disease (Table 2). Of the epilepsy groups, 66.7% of
SUDEP cases, 35.3% of high risk and 47.3% of low risk
had a lesion on the scan (Supplementary Table 2).
Voxel-based morphometry
SUDEP cases showed increased grey matter volume within
the right anterior hippocampus, and parahippocampal
gyrus (Fig. 1A), and decreased grey matter volume in the
pulvinar of the thalamus bilaterally (Fig. 1C), compared to
controls. In those at high risk, we found similar changes
within these regions, i.e. grey matter volume increase in the
right hippocampus and parahippocampal gyrus (Fig. 1B),
and decreased grey matter volume in the left pulvinar
(Fig. 1C), when compared to controls.
A post hoc analysis across all cases suggested a negative
correlation of grey matter volume within the pulvinar bi-
laterally with disease duration (Fig. 2; P5 0.005, 30 voxel
threshold extent).
Both SUDEP cases and those at high risk showed areas of
increased grey matter volume in the right hippocampus and
parahippocampal gyrus, compared to those at low risk
(threshold of significance P5 0.05, 30 voxels threshold
extent; Fig. 3).
Subgroup analyses
To ensure that the findings were not driven by gross brain
pathologies, we conducted a subgroup analysis in those at
risk who had non-lesional MRI scans (low risk n = 10; high
risk n = 22). In the majority of SUDEP cases (66.7%), le-
sions were evident on clinical scans; hence, due to small
sample size, the same subgroup analysis could not be
Table 2 Demographic and clinical parameters
SUDEP
cases (n = 12)
At high
risk (n = 34)
At low
risk (n = 19)
Controls
(n = 15)
df X2 P
Age at scan (years) Median (IQR) 33.5 (21.5) 30.5 (12) 30.0 (7.5) 37 (16) 3 2.85 0.241
Age at onset (years) Median (IQR) 16.5 (10) 13.5 (7) 14 (6) N/A 2 6.21 0.045
Epilepsy duration (years) Median (IQR) 11.5 (24.3) 17 (11.25) 15 (15) N/A 2 5.74 0.057
Gender, male 8 19 12 7 3 1.42 0.722*
43 CSs/year 8 24 0 N/A 2 26.09 0.000*
Nocturnal seizures 8 27 0 N/A 2 31.9 0.000*
Polytherapy 4 14 4 N/A 2 2.21 0.347*
Pearson’s chi-square was used for dichotomous variables. As some cells had an expected count5 5, an exact significance test was selected. Kruskal-Wallis test was used for all other
variables. CS = convulsive seizure.
P5 0.05; asterisk indicates exact P.
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conducted. Age at scan was entered as a nuisance variable.
Compared to controls, those at high risk and without le-
sions still showed increases in anterior hippocampal grey
matter volume, as well as in the amygdala, albeit this time
bilaterally (Fig. 4A). Similarly, grey matter volume in both
hippocampi and amygdalae was increased in people at high
risk compared to those at low risk, but more prominent in
the right than left amygdala and hippocampus (Fig. 4B).
To explore whether findings in the right medial temporal
lobe are only related to frequent convulsive seizures, we
compared those with more than three convulsive seizures
per year to those with fewer convulsive seizures per year in
the high risk and SUDEP groups. Fourteen subjects had
fewer convulsive seizures (four SUDEP, 10 high risk) and
32 had frequent convulsive seizures (eight SUDEP, 24 high
risk). Age at scan and gender were entered as nuisance
variables. There were no differences within the medial tem-
poral region between both groups. Compared to controls,
both groups showed common areas of increased grey
matter volume in the right hippocampus (conjunction,
P5 0.005; Fig. 5). We also compared total right hippo-
campal volumes in both groups using an automated
Figure 1 Regional grey matter volume differences between SUDEP and people at high risk and controls. (A) SUDEP cases show
increased grey matter volume in the right hippocampus and parahippocampal gyrus compared to healthy subjects. (B) Similarly to SUDEP cases,
subjects at high risk show increased grey matter volume in the right hippocampus and parahippocampal gyrus compared to healthy controls. (C)
Compared to controls, grey matter volume is decreased in SUDEP cases in the pulvinar bilaterally. (D) Likewise, grey matter volume is decreased
in those at high risk in the left pulvinar, compared to healthy controls. T-values are represented in the coloured bars. P5 0.001, 30 voxel threshold
extent; L = left; R = right.
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segmentation tool (Winston et al., 2013). There were no
significant differences in right hippocampal volumes be-
tween subjects with frequent and less frequent convulsive
seizures (right hippocampal volume in cm3 in subjects with
less than three convulsive seizures per year: median 3.036,
IQR 0.65; in subjects with three or more convulsive seiz-
ures per year: median 2.90, IQR 0.52 cm3; Mann-Whitney
U = 130.000, P = 0.646).
Figure 3 Regional grey matter volume differences between SUDEP cases and those at high risk in comparison to people at low
risk. (A) Similar to findings in comparison to controls (Fig. 1A), but at a lower threshold level (P5 0.05, 30 voxels threshold extent), SUDEP cases
show increased grey matter volume in the right hippocampus and parahippocampal gyrus in comparison to those at low risk. (B) People at high risk
and SUDEP cases share common areas of increased grey matter volume within the right hippocampus and parahippocampal gyrus when compared to
those at low risk (conjunction, P5 0.05, 30 voxels threshold extent). T-values are represented in the coloured bars. L = left; R = right.
Figure 2 Correlation of grey matter volume with disease duration. Regional grey matter volume in bilateral thalamic pulvinar shows a
negative correlation with epilepsy duration, i.e. grey matter volume decreases with longer duration (P5 0.005, 30 voxel threshold extent).
T-values are represented in the coloured bar. L = left; R = right.
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To relate seizure onset site to right medial temporal find-
ings, subjects with right temporal seizure onset were com-
pared to those with a different, right extratemporal or left
hemisphere onset. Ictal EEG data were available in nine
SUDEP, 30 high risk and four low risk individuals. In six
high risk and one SUDEP case, seizure onset could not be
localized and these cases were therefore excluded. There
were no differences between these two groups in volumetric
findings. In comparison to controls, both groups showed an
increase in grey matter volume in the right hippocampus
(P50.005, 30 voxels threshold extent; Fig. 6).
Discussion
Anatomical differences between
subjects with SUDEP and high risk
versus those at low risk
We identified increased grey matter volume within the right
hippocampus and parahippocampal gyrus in SUDEP cases
and in subjects at high risk for SUDEP, compared to those
at low risk and controls. There was increased grey matter
Figure 4 Regional grey matter volume differences between those at low and high risk with non-lesional epilepsy and controls.
Findings appear similar to previous findings in the whole sample (Fig. 1), but are more bilateral: subjects at high risk without identifiable pathology
on clinical structural scans show an increase of grey matter volume in both anterior hippocampi and amygdalae when compared to controls
(A; P5 0.001, 30 voxels threshold extent) and when compared to people at low risk (B; P5 0.005, 30 voxels threshold extent).
Grey matter volume is decreased in the bilateral posterior thalamus in those at high risk when compared to controls (C; P5 0.005, 30 voxels
threshold extent). T-values are represented in the coloured bars.
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volume in both hippocampi, extending to the amygdala
when comparing non-lesional high and low risk subjects.
The posterior thalamus (pulvinar) showed disease dur-
ation-dependent grey matter volume reduction in all patient
groups.
MRIs of all cases and controls were subsequently re-
viewed again by an experienced neuroradiologist (C.M.),
specifically looking for the presence or absence of hippo-
campal pathology (Table 1 and Supplementary Table 1).
No new lesions within these regions were identified on
visual inspection of individual cases, suggesting that the
findings are at a group level.
Neuropathological studies in sudden unexplained death
in childhood and in sudden infant death syndrome have
found abnormalities in the same region; dentate gyrus
abnormalities in a large subset of 153 sudden infant
death syndrome cases (Kinney et al., 2015) were interpreted
as a developmental vulnerability, potentially leading to re-
spiratory/autonomic instability, or even autonomic seizures
and death during sleep when challenged by homeostatic
stressors. Hippocampal and temporal lobe anomalies were
also described in 62% of sudden unexplained death in
childhood cases (Kinney et al., 2009). Microdysgenetic fea-
tures of the hippocampal formation included dentate gyrus
and subicular anomalies, granular nodular heterotopia,
subventricular neuroblasts and hamartia, all indicative of
aberrant neurodevelopment. Similar to SUDEP cases,
those sudden unexplained death in childhood individ-
uals with structural anomalies were found dead during
sleep and in the prone position, and more commonly
had an individual or family history of febrile seizures, creat-
ing a potential link between hippocampal/temporal lobe
maldevelopment, susceptibility to seizures, and sudden
death.
Increase in grey matter volume, which has appeared in
several epilepsy syndromes in previous voxel-based morph-
ometry studies (Yasuda et al., 2010), has been suggested as
indicative of dystopic neurons and diminished grey-white
matter demarcation (Yasuda et al., 2010), and findings in
the current study may therefore reflect abnormal neurode-
velopmental processes. Neuropathological studies in
SUDEP show that pathology can be present in the hippo-
campus (e.g. gliosis) (Zhuo et al., 2012). There are so far,
however, no quantitative neuropathological studies of the
hippocampus in SUDEP, which would be needed to con-
firm any subtle abnormalities such as microdysgenesis.
Increased grey matter volumes in the hippocampus may
also represent gliosis. Gliosis is a response to injury, and
includes neuronal and synaptic functional alterations
(Sofroniew, 2009) that have been associated with hyperex-
citability in epilepsy (Binder and Steinha¨user, 2006). Gliosis
within the hippocampus may therefore alter neuronal ac-
tivity facilitating the risk of SUDEP, e.g. through hyperex-
citability and/or limbic network dysfunction implicating
also autonomic function.
A recent study evaluating structural imaging prediction
patterns for seizure freedom after surgery in temporal
lobe epilepsy found unilateral or bilateral atrophy of the
hippocampus, amygdala and entorhinal cortex in most sub-
jects, although one subgroup showed bilaterally increased
hippocampal and amygdala volumes (Bernhardt et al.,
2015). Subjects in this group were more likely to have un-
successful epilepsy surgery, supporting the concept that
gliosis may facilitate processes of treatment-resistant dis-
ease. Histopathology confirmed hippocampal gliosis in
almost all subjects of this subgroup. Astrogliosis and cellu-
lar hypertrophy have been described in neuropathological
studies in hippocampal tissue of subjects with refractory
temporal lobe epilepsy (Das et al., 2012). Mild gliosis is
also present in cases of amygdala enlargement (Minami
et al., 2015).
Longitudinal voxel-based morphometry studies report a
decrease of grey matter volume in mesiotemporal structures
and the thalamus with longer disease duration and more
active disease, i.e. frequent seizures (Bernhardt et al., 2009,
2013; Coan et al., 2009). Similarly, changes in the
Figure 5 Common areas of increased grey matter volume
in subjects with frequent and less frequent convulsive
seizures compared to controls. Amongst SUDEP cases and
people at high risk of SUDEP, subjects with frequent convulsive
seizures (i.e. 53/year) and less frequent convulsive seizures (53/
year) share common areas of increased grey matter volume in the
right hippocampus when compared to healthy controls.
Conjunction, P5 0.005. T-values are represented in the coloured
bars. L = left; R = right.
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posterior thalamus correlate with disease duration in our
cohort and this suggests a dynamic origin of grey matter
volume alterations in our study. A potential mechanism for
gliosis in epilepsy could be repeated hypoxic insults, par-
ticularly through convulsive seizures (Macey et al., 2009).
That increased grey matter volume may represent gliosis
and plasticity following neural injury (Yasuda et al., 2010)
is corroborated by data in other sudden death entities:
increased grey matter volume in the putamen appears in
people with newly-diagnosed obstructive sleep apnoea,
who are subjected to repeated hypoxic episodes, with the
increased volumes usually attributed to transitional pro-
cesses in glial death accompanying the neural injury in
the syndrome (Kumar et al., 2014).
Association with autonomic
dysfunction and significance of
laterality of findings
Several functional imaging studies in humans (Shoemaker
et al., 2012, 2015), and stimulation studies in animals
(Terreberry and Neafsey, 1987) have identified the hippo-
campus as an essential component of limbic circuitry mod-
ulating autonomic function, with substantial influences on
blood pressure regulation (Harper et al., 2000).
Major hippocampal influence on autonomic activity
through efferent projections can also be assumed from
intracerebral stimulation studies in subjects with refractory
epilepsy (Catenoix et al., 2011). These influences are cor-
roborated by reports of people with mesial temporal lobe
epilepsy who show decreased heart rate variability in rela-
tion to seizures and interictal epileptic discharges, which
were more pronounced during sleep, when most cases of
SUDEP occur (Moseley et al., 2011). Of interest, heart rate
variability normalizes in some after successful temporal
lobe epilepsy surgery (Hilz et al., 2002).
Hippocampal grey matter volume increases in our cohort
may partially underlie seizure generation and ictal and peri-
ictal autonomic dysfunction. However, increased right hip-
pocampal grey matter volume was even present in those
individuals with known right medial temporal epilepsy
when compared to healthy controls (no cases of hippocam-
pal sclerosis in either group). The increased grey matter
volume was surprising, as longitudinal voxel-based morph-
ometry data describe progressive atrophy of the ipsilateral
hippocampus in the medial temporal lobe, especially in
those subjects with higher seizure frequency and longer epi-
lepsy duration, i.e. higher SUDEP risk (Bernhardt et al.,
2009, 2013; Coan et al., 2009). This may suggest that
our findings are not associated with a primarily seizure-
related autonomic dysfunction; but they may be associated
with an interictal autonomic dysregulation. At this time this
is a speculative suggestion, and needs investigation of auto-
nomic function in similar cohorts.
Asymmetry of grey matter volume
increases
A significant aspect of the grey matter volume hippocampal
increase in SUDEP cases and subjects at high risk was the
Figure 6 Grey matter volume changes in subjects with and without right temporal seizure onset. In comparison to healthy
controls, subjects with right temporal seizure onset (Fig. 6A), as well as those without (Fig. 6B) showed an increase of grey matter volume in the
right hippocampus (P5 0.005, 30 voxels threshold extent). T-values are represented in the coloured bars. L = left; R = right.
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asymmetry, with the volume changes on the right side. The
lateralization of tissue change in an autonomic regulatory
area poses a serious concern for sympathetic and parasym-
pathetic outflow. If laterality on sympathetic influences is
preserved to medullary output nuclei, the consequences to
cardiac arrhythmia generation are severe, as asymmetric
sympathetic outflow leads to such phenomena as poten-
tially fatal long Q-T syndrome (Schwartz, 1998). The
right insula plays a more prominent role with sympathetic
regulation, while parasympathetic regulation is primarily
mediated on the left insula (Oppenheimer, 2006), as deter-
mined by a series of stimulation, lesion, stroke, and ima-
ging studies, including human epilepsy surgical studies
(Oppenheimer et al., 1992). Both injury to the right
limbic system and direct insular stimulation have been asso-
ciated with sympathetic over-regulation (Oppenheimer,
2006). Sudden death after acute right-sided insular strokes
and increased complex arrhythmias appears more often
than in any other lesion localization (Soros and
Hachinski, 2012). Right insular injury in obstructive sleep
apnoea shows distorted blood pressure recovery patterns to
a challenge (Harper et al., 2003; Henderson et al., 2003)
and right hemisphere strokes, particularly when involving
the insula, are accompanied by increased nocturnal blood
pressure, higher noradrenaline levels and QTc prolonga-
tions (Oppenheimer, 2006). The insular effects appear to
be mediated by projections to the ventral medial frontal
cortex, hypothalamus, and hippocampus through inte-
grated circuitry (Shoemaker et al., 2015). The lateralized
(right) increased mesiotemporal grey matter volume in
our cohort may contribute to chronic, asymmetric hyper-
sympathetic activation, or a sympathetic system lacking in
appropriate responsiveness, which would contribute to
mechanisms that pose a risk for sudden death.
Similar scenarios develop for obstructive sleep apnoea
and for heart failure, which induce severe injury preferen-
tially in the right insula, and consequential very high rest-
ing, and unresponsive, sympathetic tone (Macey et al.,
2002; Woo et al., 2005). An imbalance between parasym-
pathetic and sympathetic drive places an individual at risk,
resulting in a tendency to postictal bradycardia/asystole as
noted in the MORTEMUS study (Ryvlin et al., 2013b).
Decreased grey matter volume in the
posterior thalamus
A second major finding was that grey matter volume was
reduced in the posterior thalamus, and correlated with dis-
ease duration. The finding was not unique to SUDEP. A
decrease of grey matter volume in the posterior thalamus
correlated with disease duration in all subjects with epi-
lepsy (Fig. 2), and one may speculate that those changes
may develop in low risk subjects, given sufficient duration
of seizures. However, the finding of posterior thalamic grey
matter volume should be taken in the context of roles for
that structure in respiratory regulation. Substantial
evidence, ranging from lesion and stimulation studies in
the foetal lamb (Koos et al., 1998, 2004), to functional
MRI studies in adolescents and children with congenital
central hypoventilation syndrome (Macey et al., 2005),
show the significant role of the posterior thalamus in med-
iating breathing responses following manipulation of
oxygen levels, with special participation in the inhibition
of breathing following hypoxic exposure (Koos et al.,
1998, 2004). We speculate that injury to the posterior thal-
amus is common in people with epilepsy, that the evidence
suggests that disease duration potentiates that injury, and
that such injury poses particular risk to the hypoxia nor-
mally accompanying ictal episodes, causing thalamic struc-
tures to fail to adequately recover from low oxygen. A
thalamic role must, however, be viewed in the context
that in people who succumbed to SUDEP or who were at
high risk also were burdened with right-sided grey matter
volume increases in the hippocampal region, which would
compromise appropriate blood pressure responses that ac-
company apnoea. Thus, the combination of injury, dimin-
ished posterior thalamic and altered right-sided
hippocampal grey matter volume may impose a set of cir-
cumstances leading to vital failure.
The mechanisms underlying decreased thalamic grey
matter volume should be considered; the decline emerges
in several epilepsy syndromes (Yasuda et al., 2010), and
appears to be, in part, independent of epilepsy severity,
presence of MRI lesions, and duration (Keller et al.,
2002). Strong relationships of disease duration and declines
in grey matter volume and changes in white matter tract
microstructure, i.e. mean fractional anisotropy declines,
have been described, and may underlie progressive brain
changes in response to active disease, i.e. recurrent seizures
(Keller et al., 2012).
High risk for SUDEP has been reported in those who fail
epilepsy surgery (Sperling et al., 2005). Persistent seizures
in subjects who had undergone amygdalo-hippocampect-
omy for unilateral temporal lobe epilepsy were associated
with preoperative atrophy of bilateral dorsomedial and pul-
vinar thalamic regions (Keller et al., 2015), with the inves-
tigators arguing that these regions are important hubs of
seizure modulation and spread. We suggest that the risk
may stem from failure of a combined interaction of breath-
ing and blood pressure control.
Limitations
The criteria used to define our risk groups, and the cut-off
between high and low risk, were arbitrary. The finding that
SUDEP and those at high risk show similar patterns is con-
sistent with our definition of risk groups. Eleven of 12
SUDEP cases were classified as high risk with our criteria.
A major limitation of our study is to disentangle whether
our finding of right hippocampal grey matter volume in-
crease is a specific SUDEP risk factor or rather a marker of
severe epilepsy.
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As there was only one low risk case in our SUDEP group,
we could not establish whether increased right hippocam-
pal grey matter volume is present in SUDEP cases despite
being labelled low risk. This would have marked our find-
ing as more SUDEP-specific. In vivo imaging biomarkers of
SUDEP risk should be present in both subjects who later on
died from, and those at high risk of, SUDEP. We argue that
the smaller the difference we observe between those two
groups, the better our classification and definition of high
risk criteria. Similarly, main risk factors for SUDEP—like
frequent, uncontrolled convulsive seizures—will have to be
present in both SUDEP and high risk groups (Hesdorffer
et al., 2011), and hence, are also the major distinguishing
factor of high risk versus low risk subjects in our study. By
the nature of SUDEP and our study, it is therefore impos-
sible to fully disentangle the effect of severe epilepsy from a
specific SUDEP biomarker itself.
Due to methodological challenges (Ashburner and
Ridgeway, 2013), there are only few longitudinal voxel-
based morphometry studies in people with mesial temporal
lobe epilepsy. All of them show grey matter atrophy within
mesial temporal structures and beyond (e.g. thalamus) over
time, which are more progressive with longer disease dur-
ation and higher seizure frequency (Bernhardt et al., 2009,
2013; Coan et al., 2009). Evaluation of subregional mesio-
temporal disease progression revealed that progressive at-
rophy particularly involves the anterior part of the
hippocampus (Bernhardt et al., 2013). These reports are
in clear contrast with our findings of increased grey
matter volume particularly in the anterior hippocampus,
and suggest that these are not only caused by frequent
seizures. There are poor data on exact seizure counts in
our groups, but when subjects in the high risk and
SUDEP groups where dichotomized into those with fre-
quent (i.e. more than three convulsive seizures per year)
and those with less frequent convulsive seizures, there
were no significant group differences within the right
hippocampus, but both groups showed common areas of
increased right hippocampal grey matter volume when
compared to healthy controls (Fig. 5). In addition, total
right hippocampal volume measures did not differ between
groups. This underscores our argument that the findings
represent more specific SUDEP markers than just markers
of severe epilepsy.
In keeping with the longitudinal data, posterior thalamic
grey matter atrophy correlates with disease duration in our
cohort and we can therefore confirm that this finding is not
a specific SUDEP biomarker.
We appreciate that epilepsy groups in this study combine
various different epilepsy subtypes, and include subjects
with lesional and non-lesional MRI scans (Supplementary
Table 2). Right hippocampal sclerosis was, however, not
present in either epilepsy group, and therefore does not
explain differences in right hippocampal grey matter
volume. Structural abnormalities were common among
our SUDEP population (66.7% of cases), and we
acknowledge that our SUDEP group may therefore not be
representative of all SUDEP cases.
A previous study (Mueller et al., 2014) described
decreased midbrain volume using graph analysis method-
ology in two SUDEP cases compared to controls. We did
not aim to examine brainstem volumes, although our
whole-brain analysis included the brainstem; we found no
abnormal changes in the brainstem within any group.
Voxel-based morphometry has substantial limitations in
evaluating brainstem segmentation, due to the difficulty in
resolving internal brainstem architecture reliably and con-
sistently (Lambert et al., 2013). Disturbances in brainstem
attributes may be better evaluated with newer procedures
for examining tissue changes, such as diffusion MRI.
Conclusion
Increased right hippocampal and parahippocampal grey
matter volume and grey matter volume decline in the pos-
terior thalamus appear to be related to SUDEP risk. In the
case of grey matter volume increases, the relationship is
independent of markers of severe epilepsy, such as frequent
convulsive seizures. The volume increases are potentially of
dynamic origin, representing gliosis in response to repetitive
injury from severe epilepsy, while the thalamic volume de-
clines may result from excitotoxic or other injury sources.
The thalamic injury may lead to an inability to recover
breathing to a hypoxic challenge from apnoea, while the
hippocampal/parahippocampal pathology may contribute
to asymmetric influences on autonomic outflow, establish-
ing circumstances for cardiac arrhythmia and hypotension.
The structural changes may be useful biomarkers to assist
determination of pathophysiology of SUDEP.
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